Roche, in its statement, said that once the new, expanded manufacturing comes on line, the company “will export more medicines from the U.S. than it imports” — though it made no ...

Compounding pharmacies use active pharmaceutical ingredients – the part of the medication that produces therapeutic effects – ...

National pharmaceutical retailer Walgreens has agreed to pay at least $300 million to settle allegations it illegally ...

There have been about $50 billion in settlements over the past several years, with the most recent being the $7.4 billion announced in January by Purdue Pharma and its owners, the Sackler family.

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing multibillion-dollar payouts, but most of the windfall is flowing to state and ...

The Purdue Boilermakers continue to produce some of the best talent in college basketball year by year. Before this season, it was Zach Edey who dominated the Big Ten. Edey capped off his ...

Christopher Julian’s opioid journey is familiar to many Americans. He was prescribed painkillers as a teenager for a series of sports injuries. He said the doctor never warned him they could be ...

(Steven Ousterman) Opioid settlements with companies such as Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing multibillion-dollar payouts, but most of the windfall is ...

A federal prosecutor in Boston who investigated the compounding pharmacy behind a deadly 2012 U.S. fungal meningitis outbreak ...

Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments, the Pittsburgh-based generics specialist said on Monday ...

Most recently, Purdue Pharma and its Sackler family owners in January reached a $7.4 billion settlement to resolve thousands of lawsuits over their pain medication OxyContin, which is widely ...

John Keenan surveys the landscape of sports betting in Massachusetts today ... do it with very aggressive marketing, much like Purdue Pharma did,” Keenan told Boston.com. The proposed solution?